GENERE NOSTRI FIDAMUS Trademark

Trademark Overview


On Wednesday, June 28, 2000, a trademark application was filed for GENERE NOSTRI FIDAMUS with the United States Patent and Trademark Office. The USPTO has given the GENERE NOSTRI FIDAMUS trademark a serial number of 76079653. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, November 14, 2009. This trademark is owned by Gelsus Research & Consulting, Inc.. The GENERE NOSTRI FIDAMUS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and consulting services related to clinical studies and trials, namely, study monitoring of phases I-IV such as site selection, investigator recruitment, CRA and regional CRS recruitment, and status and enrollment; clinical data management and analysis, namely, case report form design, database design, protocol design, clinical plan development, and statistical support and analysis; conducting safety evaluations and reports, namely, statistically analyzing data obtained from clinical trials and adverse event reports and preparing reports regarding conclusions reached; preparing reports pursuant to Centre Internationale Office de Medicale Surveillence criteria and Food and Drug Administration regulatory affairs such as IND/NDA preparation; serving as a liaison to regulatory agencies regarding clinical studies; technical medical writing for physicians and scientists in the area of obesity, gasteroenterology, allergy endocrinology, internal medicine and hypertensio...
genere nostri fidamus

General Information


Serial Number76079653
Word MarkGENERE NOSTRI FIDAMUS
Filing DateWednesday, June 28, 2000
Status710 - CANCELLED - SECTION 8
Status DateSaturday, November 14, 2009
Registration Number2703534
Registration DateTuesday, April 8, 2003
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 14, 2003

Trademark Statements


Goods and ServicesPharmaceutical research and consulting services related to clinical studies and trials, namely, study monitoring of phases I-IV such as site selection, investigator recruitment, CRA and regional CRS recruitment, and status and enrollment; clinical data management and analysis, namely, case report form design, database design, protocol design, clinical plan development, and statistical support and analysis; conducting safety evaluations and reports, namely, statistically analyzing data obtained from clinical trials and adverse event reports and preparing reports regarding conclusions reached; preparing reports pursuant to Centre Internationale Office de Medicale Surveillence criteria and Food and Drug Administration regulatory affairs such as IND/NDA preparation; serving as a liaison to regulatory agencies regarding clinical studies; technical medical writing for physicians and scientists in the area of obesity, gasteroenterology, allergy endocrinology, internal medicine and hypertension; expert witness services in the fields of clinical pharmacy and clinical pharmacology
Translation of Words in MarkThe English translation of "GENERE NOSTRI FIDAMUS" is "We believe in what we bring forth".

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, November 14, 2009
Primary Code042
First Use Anywhere DateSaturday, March 1, 1997
First Use In Commerce DateSaturday, March 1, 1997

Trademark Owner History


Party NameGelsus Research & Consulting, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10025

Party NameGelsus Research & Consulting, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10025

Party NameGelsus Research & Consulting, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10025

Trademark Events


Event DateEvent Description
Saturday, November 14, 2009CANCELLED SEC. 8 (6-YR)
Wednesday, January 9, 2008CASE FILE IN TICRS
Tuesday, April 8, 2003REGISTERED-PRINCIPAL REGISTER
Tuesday, January 14, 2003PUBLISHED FOR OPPOSITION
Wednesday, December 25, 2002NOTICE OF PUBLICATION
Monday, June 17, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 29, 2002EXAMINERS AMENDMENT MAILED
Thursday, October 25, 2001NON-FINAL ACTION MAILED
Wednesday, October 24, 2001ASSIGNED TO EXAMINER
Monday, June 11, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 2, 2001NON-FINAL ACTION MAILED
Thursday, December 21, 2000ASSIGNED TO EXAMINER